ArticleAntimicrobial agents and chemotherapy2020
Genomic Profiling of Evolving Daptomycin Resistance in a Patient with Recurrent Staphylococcus argenteus Sepsis.
Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 14 citations in OpenAlex.
- Accurately IdentifyingDiagnostics (Basel, Switzerland) · 2026Article
- Five-decade global expansion of Staphylococcus argenteus ST2250 shapes antimicrobial resistance dynamics.npj antimicrobials and resistance · 2026Article
- Implementation and outcomes of a rapid response genomic hospital epidemiology programme at an academic medical centre over 7 years.The Lancet. Microbe · 2026Review
- TheJournal of clinical microbiology · 2025Review
- TheJournal of clinical microbiology · 2025Review
- Emergence ofVirulence · 2024Article
- In host evolution of beta lactam resistance during active treatment forFrontiers in cellular and infection microbiology · 2023Article
- First Report of a Methicillin-Resistant, High-Level Mupirocin-ResistantFrontiers in cellular and infection microbiology · 2022Article
- Phenotypic and Genomic Profiling of Staphylococcus argenteus in Canada and the United States and Recommendations for Clinical Result Reporting.Journal of clinical microbiology · 2021Article
- Distribution of Virulence Factors and Resistance Determinants in Three Genotypes ofPathogens (Basel, Switzerland) · 2021Article
- Case Commentary: Daptomycin Resistance in Staphylococcus argenteus-from Northern Australia to San Francisco.Antimicrobial agents and chemotherapy · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.